Skip to main content
Caplight Logo









Izon Science

Izon Science

Private
ChristchurchHealthcare & Life Scienceshttps://www.izon.com/

Last Round

Private Equity

Jul 28, 2020

Est. Valuation

$23.04M

Total Funding Raised

$7M

Company Overview

Izon Science is a biotechnology research company that provides tools for nanoparticle measurement.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

Tunable Resistive Pulse SensingTRPSextracellular vesicle researchsize exclusion chromatographySECEV isolationnanoparticle analysisexosome isolationparticle characterizationzeta potential measurementsingle-particle analysisbiotech instrumentsnanomedicinenanopore sensinglipid nanoparticle analysistangential flow filtration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Izon Science Comparables

Compare Izon Science with similar companies based on industry and business-model similarity.

Izon Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spectradyne
82%
Exodus Bio
79%
Spheryx, Inc.
78%

Izon Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 28, 2020
VC RoundFeb 20, 2014

Key People

Founding team and executive leadership

Hans Van Der Voorn

Chief Executive Officer

Executive Team

Jules van der Voorn

COO

Executive Team

Izon Science Investors

Notable investors and investment history

Izon Science investors
InvestorRounds
Bolton EquitiesPrivate Equity
First Flight Venture CenterVC Round
Invest SouthVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 57% to 20,000.

  • Oct 26, 2024

    Monthly visitors increased 75% MoM.

Izon Science Filings

Explore SEC and related filing metadata, where available.

Izon Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Izon Science's valuation, stock price, and market status.

Is Izon Science a public or private company?

Izon Science is a private company.

What is the current stock price of Izon Science?

Izon Science is a private company with no public stock price. No recent secondary market data is available.

How much is Izon Science worth (valuation)?

Izon Science's valuation is estimated at $23.0M based on funding round data.

Can I buy Izon Science stock?

Izon Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Izon Science's last funding round?

Izon Science's most recent funding round was Private Equity on July 28, 2020.

Who are the main investors in Izon Science?

Key investors in Izon Science include Bolton Equities.

Will Izon Science IPO soon?

No public IPO plans have been announced for Izon Science.

How can I track Izon Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Izon Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChristchurch
Employee Range46
Year Founded2005
Last FundingJul 28, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?